The U.S. government has been criticized and questioned for its ineffectiveness in preventing and controlling the monkeypox epidemic.

　　Recently, the number of monkeypox cases in the United States has continued to surge. So far, more than 14,000 confirmed cases have been reported, ranking first in the world.

The U.S. government declared the monkeypox outbreak a public health emergency in the country earlier this month, and many public health experts warned that the situation might not be optimistic.

American public opinion criticized that the US government is still repeating the mistakes made during the new crown epidemic, exposing the failure of public health policy.

　　On May 18, the Massachusetts Department of Public Health reported the first confirmed case of monkeypox in the United States this year.

Over the next three months, the monkeypox virus spread rapidly across the United States.

　　The latest data from the U.S. Centers for Disease Control and Prevention shows that as of August 18, a total of 14,115 cases of monkeypox have been reported in the United States, of which New York, California, and Florida are the three states that have reported the largest number of monkeypox cases. The number reached 2744 cases.

The number of reported cases is still increasing.

　　U.S. public health experts have pointed out that the actual number of monkeypox cases in the United States may be much higher than official statistics due to insufficient testing capacity.

Most of the suspected patients are not tested in time and may spread the virus to more people.

Experts say the U.S. government is making the same mistakes of poor response it did when the new crown epidemic emerged, lagging behind and in chaos in case data collection, testing and vaccines.

　　American public opinion believes that following the ineffective response to the new crown epidemic, the U.S. government is still ineffective in responding to the monkeypox epidemic, which completely exposes the failure of the U.S. public health policy.

　　NBC News reported on the 18th that the monkeypox outbreak was a test of the U.S. public health system, and the results were disappointing.

　　The Boston Globe website recently published an article saying that U.S. public health officials and political leaders responded to the monkeypox outbreak by repeating almost every mistake they made in the 2020 response to the new crown epidemic: insufficient testing capacity, inefficient vaccine distribution, and the face of infected people seeking medical treatment. Many difficulties, the lack of communication between the government and the people, etc.

　　The U.S. government said on the 18th that it has distributed nearly 1 million doses of the "Guinios" monkeypox vaccine to various places.

However, the New York Times disclosed that experts estimate that 3.5 million doses of vaccines are currently needed to control the epidemic.

　　Faced with the dilemma of vaccine supply, the U.S. Food and Drug Administration urgently authorized a new vaccination program for monkeypox vaccine on the 9th. The vaccination method was changed from subcutaneous injection to intradermal injection.

American public opinion pointed out that this clearly shows that the government does not have enough vaccines to deal with the monkeypox epidemic.

　　The safety and efficacy of this new regimen are controversial.

Reuters reported that Bavaria Nordic, the Danish pharmaceutical company Bavaria Nordic, the maker of the "Guinios" monkeypox vaccine, questioned the safety of the new vaccination method, arguing that it lacks data to support it and that there is evidence that the intradermal injection method may lead to increased side effects.

　　The Washington Post published an article on the 17th that the U.S. government made successive mistakes in responding to the monkeypox epidemic, such as insufficient supply of monkeypox vaccines and treatments, limited testing capabilities, and dissatisfaction with vaccine manufacturers due to lowering of vaccine doses. These mistakes have intensified The already severe monkeypox epidemic situation.

　　CNN recently reported that although the US government is increasing the supply of monkeypox vaccines, there is no evidence that these vaccines are mainly provided to people at high risk of monkeypox infection.

　　In addition, the lack of data on the epidemic in the United States has also been criticized.

The US Vox website recently published an article saying that the lack of accurate data is one of the same mistakes the United States has made in the process of responding to the monkeypox epidemic and the new crown epidemic.

Responses to any outbreak must be based on access to accurate data, a capability that America's long-fragmented health system lacks.